Investor relations

Investing in ALS Global

ALS is the global benchmark for quality and integrity in the scientific testing and analysis sector. We have built our reputation on client service, innovation, quality and technical excellence. With corporate headquarters in Brisbane, Australia, and Global Operations in Houston, Texas, USA, we are an ASX100 company with a multi-billion-dollar market capitalisation.

ALS operates one of the world’s largest analytical and testing services businesses with more than 350 sites in over 65 countries across the globe. We are focused on driving growth by continuing to successfully operate our existing businesses through innovation and the pursuit of new opportunities.

ASX announcements

  • Response to ASX Appendix 3Z Query

    21 MAR 2023

    DOWNLOAD 
  • Interim CEO Key Employment Terms

    13 MAR 2023

    DOWNLOAD 
  • Final Director's Interest Notice

    10 MAR 2023

    DOWNLOAD 
  • Initial Director's Interest Notice

    10 MAR 2023

    DOWNLOAD 
  • CEO Resignation

    07 MAR 2023

    DOWNLOAD 

 

VIEW ALL

Important dates

  • Full year end

    31 MAR 2023

  • Full year results

    29 MAY 2023

  • Annual general meeting

    26 JUL 2023

  • Half year end

    30 SEP 2023

  • Half year results

    14 NOV 2023

VIEW ALL

ALS Limited

11.250
-0.089 %
ASX:ALQ
Open
11.250
High
11.290
Low
11.170
InvestorServe Log In

Important documents

Esta é uma imagem de um microfone

Financial reports

Access our half-year and full-year financial reports.

LEARN MORE
Relatórios anuais

Investors presentations

Browse through our investor presentations.

LEARN MORE
Esta é uma imagem de um microfone numa sala de reuniões

ASX announcements

View important information about our company through regular ASX announcements.

LEARN MORE

General information

Relevant information for shareholders regarding ALS Global.

VIEW MORE

Meet the directors of ALS limited

Bruce Phillips

Bruce Phillips

B Sc (Hons) (Geology)

Chairman and Independent Non-Executive Director

Bruce Phillips was appointed a Non-Executive Director of the Company on 1 August 2015 and became Chairman on 26 July 2016 following the 2016 Annual General Meeting. Bruce is a qualified geophysicist with more than 35 years of technical, financial and managerial experience in the energy sector.

Malcolm

Malcolm Deane

Master of Laws, Juris Doctor

Interim Chief Executive Officer and Managing Director

Newly appointed as Interim CEO and Managing Director for ALS Limited, Malcolm Deane has served the company in various executive positions for the past 10 years in such roles as GM for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions. Malcolm has a Master of Laws from the University of Virginia School of Law and Juris Doctor from Universidad Austral – Buenos Aires, Argentina.  

John

John Mulcahy

PhD, B E (Civil Eng) (Hons), FIE Aust

Independent Non-Executive Director

John Mulcahy was appointed a Non-Executive Director of the Company in 2012. He is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries.

Charlie

Charlie Sartain

B ENG (Hons) (Mining), FAusIMM, FTSE

Independent Non-Executive Director

Charlie Sartain was appointed a Non-Executive Director of the Company on 1 February 2015. He spent more than 30 years with MIM Holdings and then Xstrata plc after it acquired MIM. He led Xstrata’s global copper business as Chief Executive of Xstrata Copper for nine years from 2004 and prior to that held senior executive positions with the company in Latin America and Australia.

Tonianne

Tonianne Dwyer

B Juris (Hons), LLB (Hons), GAICD

Independent Non-Executive Director

Tonianne Dwyer was appointed a Non-Executive Director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets.

Siddhartha

Siddhartha Kadia

Ph.D. Biomedical Engineering, B.E., Electronics and Telecommunication

Independent Non-Executive Director

Siddhartha Kadia was appointed a Non-Executive Director of the Company in January 2019. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has a PhD in Biomedical Engineering from Johns Hopkins School of Medicine. Siddhartha has lived and worked in the US, Japan, China and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors.

Leslie

Leslie Desjardins

B. Industrial Admin, Finance (Kettering), MS. Management (MIT)

Independent Non-Executive Director

Leslie Desjardins was appointed a Non-Executive Director of the Company on 21 November 2019. She has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. Ms Desjardins is currently a Director, Audit Committee Chair, CSR/Risk Committee member with Ansell Limited and Director and Audit Committee Chair with Terry Fox Foundation, Canada.

Board Member Peter Possemiers

Peter Possemiers

B ASc., Chemistry/Microbiology, University of South Australia

Independent Non-Executive Director

Peter Possemiers has been named independent Non-Executive Director, effective November 1st, 2022. A 40-year veteran of the TIC sector, he held multiple executive leadership roles for SGS, most notably in global Environment Health and Safety, a CHF $550 million business. As Executive Vice President there, he was a member of their Operations Council with responsibility for growth and profitability, steering 15 strategic acquisitions. Mr. Possemiers is a respected leader with a deep understanding of TIC practices across multiple regions. His M&A track record and network relationships will provide invaluable insight and benefits for ALS Limited.

Investing in ALS Global

42%

Dividend paid per share (cents) is 42.0% up to 32.8 cents per share

$2.18B

Revenue for financial year 2022 was $2.182 billion (AUD)

$264M

Net profit after tax was $264.2 million (AUD)

39.5CPS

Statutory earnings per share for financial year 2022 was 39.5 cents per share (CPS)

ALS pillars

This is an image of people walking

Employees first

Being a global leader means assembling the right teams. We pride ourselves in recruiting top talent and offering a safe, inclusive, educational environment with the necessary resources to inspire continued growth.

  • Ensure a healthy work environment
    • Mandate critical safety guidelines
    • Provide health and wellness programs
    • Ensure supportive resources
  • Attract and develop a diverse workforce
    • Explore unconscious bias recruitment training
    • Build on reward/recognition programs
    • Invest in employee training and professional enrichment opportunities
    • Further develop inclusion initiatives
Environment

Taking steps to reduce our footprint

Environmental responsibility is a priority. Throughout our field work, we regularly seek opportunities to minimize our impact by conserving resources, reducing waste and more using more sustainable material.

  • Helping to minimize our carbon footprint
    • Tracking of carbon reduction plans for each business
    • Procurement of renewable energy
Society

Global services. Local partners.

ALS offers testing and inspection services that help people all over the world. Through these efforts, we contribute to communities by creating shared value with our local partners. This includes providing employment opportunities and partnering with local contractors and suppliers.

  • Generating opportunities while giving back
    • Create jobs
    • Promote science education programs for students in local schools and universities
  • Stimulate local economies
    • Provide tax revenues across various countries in which we operate
    • Deliver high returns and create long-term value for shareholders
  • Uphold human rights
    • Recognize worker's rights across our global network
    • Maintain a safe and supportive work environment
    • Assessing working practices to ensure that human rights are respected
Governance

Operating ethically and responsibly

We hold ourselves to high standards of professional integrity. Regulatory frameworks promoting transparency and accountability allow us to build a trusting relationship with our stakeholders.

  • Maintain a fair workplace
    • Promote both an honest and ethical environment
  • Execute Enterprise Risk Management
    • Deliver sustainable outcomes for stakeholders
Key Contact image or woman and man talking

Key contacts

A list of key contact people within ALS Limited who are available to help you with various Investor related queries. For more information please contact:

enquiries@boardroomlimited.com.au www.boardroomlimited.com.au
ALS Limited

PO Box 66
Everton Park, Queensland
Australia 4053

T: +61 (0)7 3367 7900

F: +61 (0)7 3367 8156

BoardRoom Pty Ltd

Share Registry
PO Box 3993
Sydney, NSW
2001 Australia

T: 1300 737 760

F: +61 (0)2 9279 0664

Investor Relation Enquiries Cameron Sinclair

Level 14, 385 Bourke Street
Melbourne VIC
3000 Australia

M: +61 412 430 393

c.sinclair@alsglobal.com

 

 

GENERAL INFORMATION